1463502-41-1 Usage
Uses
Used in Organic Synthesis:
Tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure, including the triple bond and the carboxylate ester functionality, allows for versatile chemical reactions and the formation of a wide range of products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate is utilized as a building block for the development of novel drug candidates. Its structural features can be incorporated into drug molecules to modulate their properties, such as solubility, stability, and biological activity. tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate may contribute to the discovery of new therapeutic agents with improved efficacy and safety profiles.
Used in Industrial Processes:
Tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate may also find applications in various industrial processes, such as the synthesis of specialty chemicals, materials, and coatings. Its unique chemical properties can be harnessed to create innovative products with specific performance characteristics, addressing the needs of different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1463502-41-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,6,3,5,0 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1463502-41:
(9*1)+(8*4)+(7*6)+(6*3)+(5*5)+(4*0)+(3*2)+(2*4)+(1*1)=141
141 % 10 = 1
So 1463502-41-1 is a valid CAS Registry Number.
1463502-41-1Relevant articles and documents
?-LACTAMASE INHIBITOR AND USE THEREOF
-
Paragraph 0206; 0209, (2020/12/10)
Provided are a β-lactamase inhibitor of formula (I), or an ester, a stereoisomer or a pharmaceutically acceptable salt thereof, and a method of preparing the same. Further provided is a pharmaceutical composition comprising the β-lactamase inhibitor of formula (I), or the ester, the stereoisomer or pharmaceutically acceptable salt thereof. In addition, the present invention relates to a method for treating diseases caused by bacterial infection, which comprises administering the β-lactamase inhibitor of formula (I), or the ester, the stereoisomer or the pharmaceutically acceptable salt thereof to a patient or a subject in need.
MERTK DEGRADERS AND USES THEREOF
-
, (2020/01/31)
The present invention provides compounds, compositions thereof, and methods of using the same.
ANTIBACTERIAL AGENTS
-
, (2014/10/18)
Antibacterial compounds of formula (I) are provided, as well as stereoisomers and pharmaceutically acceptable salts and esters thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.
ISOXAZOLE β-LACTAMASE INHIBITORS
-
Page/Page column 73; 74, (2013/10/21)
β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
